Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Non-Current Deffered Revenue (2017 - 2018)

Cogent Biosciences has reported Non-Current Deffered Revenue over the past 2 years, most recently at $748000.0 for Q4 2018.

  • Quarterly results put Non-Current Deffered Revenue at $748000.0 for Q4 2018, down 91.42% from a year ago — trailing twelve months through Dec 2018 was $748000.0 (down 91.42% YoY), and the annual figure for FY2018 was $748000.0, down 91.42%.
  • Non-Current Deffered Revenue for Q4 2018 was $748000.0 at Cogent Biosciences, down from $871000.0 in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for COGT hit a ceiling of $8.7 million in Q4 2017 and a floor of $346000.0 in Q2 2018.